Epidemiology of fungal infections : the promise of molecular typingPFALLER, M. A.Clinical infectious diseases. 1995, Vol 20, Num 6, pp 1535-1539, issn 1058-4838Article

Laboratory aids in the diagnosis of invasive candidiasisPFALLER, M. A.Mycopathologia (1975). 1992, Vol 120, Num 2, pp 65-72, issn 0301-486XArticle

The use of molecular techniques for epidemiologic typing of Candida speciesPFALLER, M. A.Current topics in medical mycology. 1992, Vol 4, pp 43-63, issn 0177-4204Article

The use of the prompt inoculation system^® in preparing a standardized yeast inoculumPFALLER, M. A; GERARDEN, T.American journal of clinical pathology. 1987, Vol 88, Num 6, pp 743-745, issn 0002-9173Article

Susceptibility of clinical isolates of Candida spp. to terconazole and other azole antifungal agentsPFALLER, M. A; GERARDEN, T.Diagnostic microbiology and infectious disease. 1989, Vol 12, Num 6, pp 467-471, issn 0732-8893Article

Molecular epidemiology in the care of patients : Molecular pathology : Role in improving patient outcomePFALLER, M. A.Archives of pathology & laboratory medicine (1976). 1999, Vol 123, Num 11, pp 1007-1010, issn 0363-0153Conference Paper

In vitro evaluation of contemporary β-lactam drugs tested against viridans group and β-haemolytic streptococciPFALLER, M. A; JONES, R. N.Diagnostic microbiology and infectious disease. 1997, Vol 27, Num 4, pp 151-154, issn 0732-8893Article

Comparative antistreptococcal activity of two newer fluoroquinolones, levofloxacin and sparfloxacinPFALLER, M. A; JONES, R. N.Diagnostic microbiology and infectious disease. 1997, Vol 29, Num 3, pp 199-201, issn 0732-8893Article

Application of CHROMagar Candida for rapid screening of clinical specimens for Candida albicans, Candida tropicalis, Candida krusei, and Candida (Torulopsis) glabrataPFALLER, M. A; HOUSTON, A; COFFMANN, S et al.Journal of clinical microbiology (Print). 1996, Vol 34, Num 1, pp 58-61, issn 0095-1137Article

Epidemiology of candidiasisCORMICAN, M. G; PFALLER, M. A.Comprehensive therapy. 1995, Vol 21, Num 11, pp 653-657, issn 0098-8243Article

Application of new technology to the detection, identification, and antimicrobial susceptibility testing of mycobacteriaPFALLER, M. A.American journal of clinical pathology. 1994, Vol 101, Num 3, pp 329-337, issn 0002-9173Conference Paper

Epidemiological typing methods for mycosesPFALLER, M. A.Clinical infectious diseases. 1992, Vol 14, pp S4-S10, SUP1Conference Paper

A review of the in vitro activity of meropenem and comparative antimicrobial agents tested against 30,254 aerobic and anaerobic pathogens isolated world widePFALLER, M. A; JONES, R. N.Diagnostic microbiology and infectious disease. 1997, Vol 28, Num 4, pp 157-163, issn 0732-8893Article

In vitro susceptibilities of clinical yeast isolates to a new echinocandin derivative, LY303366, and other antifungal agentsPFALLER, M. A; MESSER, S. A; COFFMAN, S et al.Antimicrobial agents and chemotherapy. 1997, Vol 41, Num 4, pp 763-766, issn 0066-4804Article

Clinical evaluation of a dried commercially-prepared microdilution panel for antifungal susceptibility testingMESSER, S. A; PFALLER, M. A.Diagnostic microbiology and infectious disease. 1996, Vol 25, Num 2, pp 77-81, issn 0732-8893Article

Feasible and desirable future targets for reducing the costs of hospital infectionsWENZEL, R. P; PFALLER, M. A.The Journal of hospital infection. 1991, Vol 18, pp 94-98, issn 0195-6701, 5 p., SUPAConference Paper

Polyamine depletion and growth inhibition of Cryptococcus neoformans by α-difluoromethylornithine and cyclohexylaminePFALLER, M. A; RILEY, J; GERARDEN, T et al.Mycopathologia (1975). 1990, Vol 112, Num 1, pp 27-32, issn 0301-486X, 6 p.Article

Use of rapid screening tests in processing urine specimens by conventional culture and the automicrobic systemPFALLER, M. A; KOONTZ, F. P.Journal of clinical microbiology (Print). 1985, Vol 21, Num 5, pp 783-787, issn 0095-1137Article

Oxygen enhances the antimalarial activity of the imidazolesPFALLER, M. A; KROGSTAD, D. J.The American journal of tropical medicine and hygiene. 1983, Vol 32, Num 4, pp 660-665, issn 0002-9637Article

Variation in electrophoretic karyotype and antifungal susceptibility of clinical isolates of Cryptococcus neoformans at a University-affiliated teaching Hospital from 1987 to 1994KLEPSER, M. E; PFALLER, M. A.Journal of clinical microbiology (Print). 1998, Vol 36, Num 12, pp 3653-3656, issn 0095-1137Article

The clinical microbiology laboratory and infection control: Emerging pathogens, antimicrobial resistance, and new technologyPFALLER, M. A; HERWALDT, L. A.Clinical infectious diseases. 1997, Vol 25, Num 4, pp 858-870, issn 1058-4838Article

Nosocomial candidiasis : Emerging species, reservoirs, and modes of transmissionPFALLER, M. A.Clinical infectious diseases. 1996, Vol 22, pp S89-S94, issn 1058-4838, SUP2Conference Paper

In vitro susceptibilities of clinical yeast isolates to three antifungal agents determined by the microdilution methodPFALLER, M. A; BARRY, A. L.Mycopathologia (1975). 1995, Vol 130, Num 1, pp 3-9, issn 0301-486XArticle

Growth inhibition of pathogenic yeast isolates by α-difluoromethylornithine: an inhibition of ornithine decarboxylasePFALLER, M. A; GIRARDEN, T; RILEY, J et al.Mycopathologia (1975). 1987, Vol 98, Num 1, pp 3-8, issn 0301-486XArticle

Epidemiology of invasive candidiasis : a persistent public health problemPFALLER, M. A; DIEKEMA, D. J.Clinical microbiology reviews (Print). 2007, Vol 20, Num 1, pp 133-163, issn 0893-8512, 31 p.Article